Literature DB >> 20210043

Meningitis in Chad, Niger and Nigeria: 2009 epidemic season.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20210043

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  11 in total

1.  Epidemiologic pattern of meningococcal meningitis in northern Cameroon in 2007-2010: contribution of PCR-enhanced surveillance.

Authors:  Denis Massenet; Jacques Birguel; François Azowé; Clifford Ebong; Bouba Gake; Jean-Pierre Lombart; Pascal Boisier
Journal:  Pathog Glob Health       Date:  2013-01       Impact factor: 2.894

2.  Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.

Authors:  Matthew J Ferrari; Florence Fermon; Fabienne Nackers; Augusto Llosa; Claire Magone; Rebecca F Grais
Journal:  Int Health       Date:  2014-09-05       Impact factor: 2.473

3.  Concomitant administration of Mycobacterium bovis BCG with the meningococcal C conjugate vaccine to neonatal mice enhances antibody response and protective efficacy.

Authors:  Siggeir F Brynjolfsson; Stefania P Bjarnarson; Elena Mori; Giuseppe Del Giudice; Ingileif Jonsdottir
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

Review 4.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

Review 5.  The development of global vaccine stockpiles.

Authors:  Catherine Yen; Terri B Hyde; Alejandro J Costa; Katya Fernandez; John S Tam; Stéphane Hugonnet; Anne M Huvos; Philippe Duclos; Vance J Dietz; Brenton T Burkholder
Journal:  Lancet Infect Dis       Date:  2015-02-06       Impact factor: 25.071

6.  Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010.

Authors:  Sung Hye Kim; Lorenzo Pezzoli; Harouna Yacouba; Tiekoura Coulibaly; Mamoudou H Djingarey; William A Perea; Thomas F Wierzba
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

7.  Significant sequelae after bacterial meningitis in Niger: a cohort study.

Authors:  Jean-François Jusot; Zilahatou Tohon; Abdoul Aziz Yazi; Jean-Marc Collard
Journal:  BMC Infect Dis       Date:  2013-05-21       Impact factor: 3.090

8.  Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.

Authors:  Paulo Ferrinho; Mohammed Dramé; Prosper Tumusiime
Journal:  Pan Afr Med J       Date:  2013-06-07

9.  Travel-related Neisseria meningitidis serogroup W135 infection, France.

Authors:  Muhamed-Kheir Taha; Adèle Kacou-N'douba; Eva Hong; Ala Eddine Deghmane; Dario Giorgini; Sophia Lurette Okpo; Tatiana Kangah; Mireille Dosso
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

10.  Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Authors:  D M Daugla; J P Gami; K Gamougam; N Naibei; L Mbainadji; M Narbé; J Toralta; B Kodbesse; C Ngadoua; M E Coldiron; F Fermon; A-L Page; M H Djingarey; S Hugonnet; O B Harrison; L S Rebbetts; Y Tekletsion; E R Watkins; D Hill; D A Caugant; D Chandramohan; M Hassan-King; O Manigart; M Nascimento; A Woukeu; C Trotter; J M Stuart; McJ Maiden; B M Greenwood
Journal:  Lancet       Date:  2013-09-12       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.